References
  1. Venkatesh K, Priyanka T, Rukmini NS, Bisanna J. Chondroblastic Variant of Osteosarcoma of Mandible: Report of a Rare Case. J Clin Diagn Res. 2016 Aug;10(8):ED12-4. doi: 10.7860/JCDR/2016/20150.8341. Epub 2016 Aug 1. PMID: 27656455; PMCID: PMC5028578.
  2. Raymond AK, Ayala AG, Knuutila S. Conventional Osteo- sarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: IARC Press; 2002. p. 264-70.
  3. Kundu ZS. Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop. 2014 May;48(3):238-46. doi: 10.4103/0019-5413.132491. PMID: 24932027; PMCID: PMC4052020.
  4. Oliveira, L. G. R., Cunha, J. L. S., Bezerra, B. T., Melo, M. de F. B., Fonte, J. B. M., & Albuquerque Jr., R. L. C.. (2018). Chondroblastic osteosarcoma of the mandible: case report. Jornal Brasileiro De Patologia E Medicina Laboratorial , 54 (J. Bras. Patol. Med. Lab., 2018 54(2)), 111–115. https://doi.org/10.5935/1676-2444.20180021
  5. Kedar S, Nagle S, Agarwal S, Bage S, Kothekar A, et al. (2013) Giant Chondroblastic Osteosarcoma Mandible-A Rare Case Report. Otolaryngology 3:146. Doi: 10.4172/2161-119X.1000146
  6. Oliveira, L. G. R., Cunha, J. L. S., Bezerra, B. T., Melo, M. de F. B., Fonte, J. B. M., & Albuquerque Jr., R. L. C.. (2018). Chondroblastic osteosarcoma of the mandible: case report. Jornal Brasileiro De Patologia E Medicina Laboratorial , 54 (J. Bras. Patol. Med. Lab., 2018 54(2)), 111–115. https://doi.org/10.5935/1676-2444.20180021
  7. Smeele LE, Kostense PJ, van der Waal I, Snow GB: Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol. 1997, 15:363-7. 10.1200/JCO.1997.15.1.363
  8. Wang D, Luo M, Kelley MR: Human apurinic endonuclease 1 (APE1) expression and prognostic significance in osteosarcoma: enhanced sensitivity of osteosarcoma to DNA damaging agents using silencing RNA APE1 expression inhibition. Mol Cancer Ther. 2004, 3:679-86.
  9. Uozaki H, Horiuchi H, Ishida T, Iijima T, Imamura T, Machinami R: Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer. 1997, 79:2336-44. 10.1002/(sici)1097-0142(19970615)79:12<2336::aid-cncr7>3.0.co;2-j
  10. He H, Ni J, Huang J: Molecular mechanisms of chemoresistance in osteosarcoma (Review). Oncol Lett. 2014, 7:1352-62. 10.3892/ol.2014.1935
  11. Liu JJ, Liu S, Wang JG, Zhu W, Hua YQ, Sun W, Cai ZD. Telangiectatic osteosarcoma: a review of literature. Onco Targets Ther. 2013 May 28;6:593-602. doi: 10.2147/OTT.S41351. PMID: 23745051; PMCID: PMC3671797.